Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization.

Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. HPB Surg. 2016;2016:6120143 Authors: Ahmed S, de Souza NN, Qiao W, Kasai M, Keem LJ, Shelat VG Abstract Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients. PMID: 27143815 [PubMed]
Source: HPB Surgery - Category: Surgery Tags: HPB Surg Source Type: research